不安障害(Anxiety Disorder)治療薬の世界市場2015-2019...市場調査レポートについてご紹介

【英文タイトル】Global Anxiety Disorders Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Types of anxiety disorders

07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis

08.Market Segmentation by Drug Class

09.Geographical Segmentation

10.Buying Criteria

11.Market Growth Drivers

12.Drivers and their Impact

13.Market Challenges

14.Impact of Drivers and Challenges

15.Market Trends

16.Trends and their Impact

17.Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.2.1 Eli Lilly
17.2.2 Pfizer
17.2.3 GlaxoSmithKline
17.3 Other Prominent Vendors

18.Key Vendor Analysis
18.1 Eli Lilly
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation by Revenue
18.1.4 Sales by Geography
18.1.5 Business Strategy
18.1.6 Key Information
18.1.7 SWOT Analysis
18.2 GlaxoSmithKline
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation
18.2.4 Business Segmentation by Revenue 2012 and 2013
18.2.5 Sales by Geography
18.2.6 Pipeline Products
18.2.7 Business Strategy
18.2.8 Key Information
18.2.9 SWOT Analysis
18.3 Pfizer
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Business Segmentation by Revenue 2012 and 2013
18.3.5 Geographical Segmentation by Revenue
18.3.6 Business Strategy
18.3.7 Key Developments
18.3.8 SWOT Analysis

19.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Classification of Anxiety Disorders
Exhibit 3: GAD: Disease Overview
Exhibit 4: Panic Disorder: Disease Overview
Exhibit 5: OCD: Disease Overview
Exhibit 6: PTSD: Disease Overview
Exhibit 7: Social Anxiety Disorder: Disease Overview
Exhibit 8: Specific Phobias: Disease Overview
Exhibit 9: BDD: Disease Overview
Exhibit 10: Global Anxiety Disorders Market 2014-2019 (US$ billion)
Exhibit 11: Global Anxiety Disorders Market Segmentation by Drug Class
Exhibit 12: Segmentation of Global Anxiety Disorders Market by Geography 2014
Exhibit 13: Cymbalta: Basic Information
Exhibit 14: Cymbalta Revenue 2011-9M 2014 (US$ million)
Exhibit 15: Revenue Segmentation by Geography 9M 2014
Exhibit 16: Pfizer: Revenue of Key Anti-Anxiety Products 9M 2014 (US$ million)
Exhibit 17: Lyrica: Basic Information
Exhibit 18: Lyrica Revenue 2011-9M 2014 (US$ million)
Exhibit 19: Revenue Segmentation by Geography 9M 2014
Exhibit 20: Zoloft: Basic Information
Exhibit 21: Zoloft Revenue 2011-9M 2014 (US$ million)
Exhibit 22: Revenue Segmentation by Geography 9M 2014
Exhibit 23: Effexor and Effexor XR: Basic Information
Exhibit 24: Effexor/Effexor XR Revenue 2011-9M 2014 (US$ million)
Exhibit 25: Revenue Segmentation by Geography 9M 2014
Exhibit 26: Xanax and Xanax XR: Basic Information
Exhibit 27: Xanax/Xanax XR Revenue 2011-9M 2014 (US$ million)
Exhibit 28: Revenue Segmentation by Geography 9M 2014
Exhibit 29: Seroxat/Paxil/Paxil CR: Basic Information
Exhibit 30: Seroxat/Paxil Revenue 2011-9M 2014 (US$ million)
Exhibit 31: Revenue Segmentation by Geography 9M 2014
Exhibit 32: Eli Lilly: Business Segmentation by Revenue 2013
Exhibit 33: Eli Lilly: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 34: Eli Lilly: Sales by Geography 2013
Exhibit 35: GlaxoSmithKline plc: Business Segmentation 2013
Exhibit 36: GlaxoSmithKline plc: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 37: GlaxoSmithKline plc: Sales by Geography 2013
Exhibit 38: GlaxoSmithKline plc: Pipeline Products 2013
Exhibit 39: Pfizer: Business Segmentation by Revenue 2013
Exhibit 40: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 41: Pfizer: Geographical Segmentation by Revenue 2013


【レポート販売概要】

■ タイトル:不安障害(Anxiety Disorder)治療薬の世界市場2015-2019
■ 英文:Global Anxiety Disorders Market 2015-2019
■ 発行日:2015年1月14日
■ 調査会社:Technavio
■ 商品コード:IRTNTR5051
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。